» Articles » PMID: 23533243

Endocrine Profile and Phenotype-(epi)genotype Correlation in Spanish Patients with Pseudohypoparathyroidism

Overview
Specialty Endocrinology
Date 2013 Mar 28
PMID 23533243
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Recent advances in genetics and epigenetics have revealed an overlap between molecular and clinical features of pseudohypoparathyroidism (PHP) subtypes, broadening the previous spectrum of PHP genotype-phenotype correlations and indicating limitations of the current classification of the disease.

Objectives: The aim of the study was to screen patients with clinical diagnoses of PHP type I or pseudo-PHP for underlying molecular defects and explore possible correlations between molecular findings and clinical features.

Patients And Methods: We investigated the GNAS locus at the molecular level in 72 affected patients (46 women and 26 men) from 56 nonrelated families. Clinical data were obtained for 63 of these patients (38 women and 25 men).

Results: The molecular analysis showed that 35 patients carried structural mutations, 32 had loss of methylation, and 2 had a 2q37 deletion but did not reveal any (epi)mutation for 3 patients. Comparing these results and the clinical data, we observed that a younger age at diagnosis was associated with structural defects at the GNAS gene and epigenetic defects with a diagnosis later in life (9.19 ± 1.64 vs 24.57 ± 2.28 years, P < .0001).

Conclusions: This first global review of PHP in Spain highlights the importance of a detailed clinical and genetic study of each patient and the integrated analysis of the findings from the two approaches. It may also help geneticists and clinicians to raise the suspicion of PHP earlier, reach more accurate diagnoses, and provide patients with PHP and their families with useful genetic information and counseling, thereby improving outcomes and quality of life.

Citing Articles

Growth Hormone Deficiency in an Adolescent With Pseudohypoparathyroidism Type 1B.

Sasidharan Pillai S, Reyes M, Juppner H, Topor L JCEM Case Rep. 2024; 2(9):luae152.

PMID: 39193092 PMC: 11348937. DOI: 10.1210/jcemcr/luae152.


locus: bone related diseases and mouse models.

Yang W, Zuo Y, Zhang N, Wang K, Zhang R, Chen Z Front Endocrinol (Lausanne). 2023; 14:1255864.

PMID: 37920253 PMC: 10619756. DOI: 10.3389/fendo.2023.1255864.


Rare Case of Pseudohypoparathyroidism With Normocalcemia Because of a Novel GNAS Mutation.

Mangu G, Malik S, Eranki V JCEM Case Rep. 2023; 1(4):luad088.

PMID: 37908988 PMC: 10580659. DOI: 10.1210/jcemcr/luad088.


New insights into thyroid dysfunction in patients with inactivating parathyroid hormone/parathyroid hormone-related protein signalling disorder (the hormonal and ultrasound aspects): One-centre preliminary results.

Janus D, Roztoczynska D, Janeczko M, Starzyk J Front Endocrinol (Lausanne). 2022; 13:1012658.

PMID: 36213284 PMC: 9539917. DOI: 10.3389/fendo.2022.1012658.


Evaluating the variety of GNAS inactivation disorders and their clinical manifestations in 11 Chinese children.

Chang G, Li Q, Li N, Li G, Li J, Ding Y BMC Endocr Disord. 2022; 22(1):70.

PMID: 35296306 PMC: 8928694. DOI: 10.1186/s12902-022-00941-8.